Conmed Corp (CNMD) Reports In-Line Q2 EPS; Guides Q3
Tweet
Share
E-mailGet Alerts CNMD Hot Sheet
Price: $32.54 -0.12%
Revenue Growth %: -0.5%
Financial Fact:
Net sales: 184.79M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: -0.5%
Financial Fact:
Net sales: 184.79M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Conmed Corp (NASDAQ: CNMD) reported Q2 EPS of $0.35, in-line with the analyst estimate of $0.35. Revenue for the quarter came in at $183.2 million versus the consensus estimate of $185.81 million.
Conmed Corp sees Q3 2011 EPS of $0.29-$0.33, versus the consensus of $0.33. Sees revs down slightly sequentially.
Conmed Corp sees Q3 2011 EPS of $0.29-$0.33, versus the consensus of $0.33. Sees revs down slightly sequentially.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Kroger (KR) Reports In-Line Q1 EPS, Beats on Revenue; Offers FY27 EPS Guidance
- Nucor guides Q2 2026 earnings to $4.70-$4.80 per diluted share
- Jabil beats consensus estimates but shares dip
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
